ICER blasts FDA, PTC and Sarepta for high prices on DMD drugs Emflaza, Exondys 51
ICER has some strong words for PTC, Sarepta and the FDA as the US drug price watchdog concludes that as currently priced, their respective …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
